Folaranmi TA - Search Results

1

Increased Risk for Meningococcal Disease Among Men Who Have Sex With Men in the United States, 2012-2015.

Folaranmi TA, Kretz CB, Kamiya H, MacNeil JR, Whaley MJ, Blain A, Antwi M, Dorsinville M, Pacilli M, Smith S, Civen R, Ngo V, Winter K, Harriman K, Wang X, Bowen VB, Patel M, Martin S, Misegades L, Meyer SA. Folaranmi TA, et al. Clin Infect Dis. 2017 Sep 1;65(5):756-763. doi: 10.1093/cid/cix438. Clin Infect Dis. 2017. PMID: 28505234 Free PMC article.

2

Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015.

Folaranmi T, Rubin L, Martin SW, Patel M, MacNeil JR; Centers for Disease Control (CDC). Folaranmi T, et al. MMWR Morb Mortal Wkly Rep. 2015 Jun 12;64(22):608-12. MMWR Morb Mortal Wkly Rep. 2015. PMID: 26068564 Free PMC article.

3

Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015.

MacNeil JR, Rubin L, Folaranmi T, Ortega-Sanchez IR, Patel M, Martin SW. MacNeil JR, et al. MMWR Morb Mortal Wkly Rep. 2015 Oct 23;64(41):1171-6. doi: 10.15585/mmwr.mm6441a3. MMWR Morb Mortal Wkly Rep. 2015. PMID: 26492381 Free article.

4

Systematic review and meta-analysis of pertussis epidemiology in Latin America and the Caribbean: 1980-2015.

Folaranmi T, Pinell-McNamara V, Griffith M, Hao Y, Coronado F, Briere EC. Folaranmi T, et al. Rev Panam Salud Publica. 2017 Nov 17;41:e102. doi: 10.26633/RPSP.2017.102. eCollection 2017. Rev Panam Salud Publica. 2017. PMID: 31384251 Free PMC article.

5

Immunogenicity following revaccination or sequential vaccination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in older adults and those at increased risk of pneumococcal disease: a review of the literature.

Cripps AW, Folaranmi T, Johnson KD, Musey L, Niederman MS, Buchwald UK. Cripps AW, et al. Expert Rev Vaccines. 2021 Mar;20(3):257-267. doi: 10.1080/14760584.2021.1889374. Epub 2021 Mar 2. Expert Rev Vaccines. 2021. PMID: 33567914 Review.

6

Response to Shami et al. 'Evaluating the cost-effectiveness of a sequential pneumococcal vaccination compared to single dose vaccination strategy for adults in Hong Kong' (Hum Vacc Immunother 2020).

Buchwald UK, Folaranmi T, Weiss T. Buchwald UK, et al. Hum Vaccin Immunother. 2021 Jan 2;17(1):173-175. doi: 10.1080/21645515.2020.1764828. Epub 2020 Jul 2. Hum Vaccin Immunother. 2021. PMID: 32614654 Free PMC article.

7

The Japanese 23-valent pneumococcal polysaccharide vaccine randomized clinical trial: Further reflections on the design and results.

Cui YA, Folaranmi T, Buchwald UK. Cui YA, et al. Vaccine. 2021 Jan 22;39(4):641-643. doi: 10.1016/j.vaccine.2020.12.033. Epub 2020 Dec 23. Vaccine. 2021. PMID: 33358263 Clinical Trial.

8

Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older.

Buchwald UK, Andrews CP, Ervin J, Peterson JT, Tamms GM, Krupa D, Ajiboye P, Roalfe L, Krick AL, Sterling TM, Wang M, Martin JC, Stek JE, Kohn MA, Folaranmi T, Abeygunawardana C, Hartzel J, Musey LK; V110–029 Study Group. Buchwald UK, et al. Hum Vaccin Immunother. 2021 Aug 3;17(8):2678-2690. doi: 10.1080/21645515.2021.1888621. Epub 2021 May 21. Hum Vaccin Immunother. 2021. PMID: 34019468 Free PMC article.

9

Efficacy and effectiveness of a 23-valent polysaccharide vaccine against invasive and noninvasive pneumococcal disease and related outcomes: a review of available evidence.

Niederman MS, Folaranmi T, Buchwald UK, Musey L, Cripps AW, Johnson KD. Niederman MS, et al. Expert Rev Vaccines. 2021 Mar;20(3):243-256. doi: 10.1080/14760584.2021.1880328. Epub 2021 Feb 20. Expert Rev Vaccines. 2021. PMID: 33478306 Review.

10

A Japanese nationwide survey of 23-valent pneumococcal capsular polysaccharide vaccine (PPSV23) coverage among patients with chronic medical condition aged 50 and older.

Kawakami K, Nakamura A, Wakana A, Folaranmi TA, Iino T. Kawakami K, et al. Among authors: folaranmi ta. Hum Vaccin Immunother. 2020 Jul 2;16(7):1521-1528. doi: 10.1080/21645515.2019.1690332. Epub 2019 Dec 4. Hum Vaccin Immunother. 2020. PMID: 31799889 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page